Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
study transitioned from LIRB to CIRB
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In order to ensure the equity of the liver allocation process, it is important to create objective, scientifically validated markers of frailty in patients with end-stage liver disease that accurately predict patient outcomes. Many measures have been developed to assess this clinical state in elderly patients, but none have been applied to patients with cirrhosis, a population at increased risk for accelerated functional decline. This protocol is designed to learn more about the effects of functional status (also known as "frailty") in liver transplant patients and patient outcomes both before and after liver transplant.
Subjects in this study will be asked questions regarding functional status and ability to do activities at home. Subjects will also be asked to complete several physical tests to assess functional status. For example, subjects will be asked to stand up from a chair several times, balance with their feet together, and walk down a hall as quickly as possible. Subjects will also be asked to perform a hand grip strength test.
Subjects will be assessed at baseline and at every clinic visit in the pre-transplant setting. Subjects will again be assessed at 3, 6, and 12 months post-transplant.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Fried Frailty Index measurements in 300 patients with end-stage liver disease awaiting liver transplantation | Fried Frailty is calculated by combining into one score measurements of:
Range of score is 0 to 5 with 0 being not frail and 5 being most frail | 5 years |
| Liver Frailty Index measurements in 300 patients with end-stage liver disease awaiting liver transplantation | The following measurements are used individually to assess liver frailty index: Chair stands: The patient stands up from a sitting position without using his/her arms. The time (in seconds) the patient requires to complete the task is reported. Balance testing: patients must stand up in side by side, semi tandem and tandem positions for 10 seconds each. If the subject can't hold position for 10 seconds, the number of seconds that the subject kept in position is reported. Scoring range is 1.0 to 7.0 with 1.0 to 3.0 being "robust" and 4.5 to 7.0 being "frail" | 5 years |
| Numbers Connection test measurements in 300 patients with end-stage liver disease | Patient connects numbers that are scattered at random on a piece of paper. Reported as time (in seconds) taken to connect the numbers. | 5 years |
| Work status | Possible answers: working, retired, on disability, other. | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation between frailty and outcomes both before and after liver transplantation. | The association between the subject's frailty score and their pre and post transplant outcomes will be assessed. | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Change in measurements of fried frailty before and after liver transplantation. | The changes in frailty score pre and post transplant will be evaluated. | 5 years |
| Change in measurements of liver frailty before and after liver transplantation. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Enrolled from Baylor University Medical Center.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| James Trotter, MD | Baylor Health Care System | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Baylor University Medical Center | Dallas | Texas | 75246 | United States |
Not provided
| ID | Term |
|---|---|
| D005355 | Fibrosis |
| D058625 | End Stage Liver Disease |
| D000073496 | Frailty |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D017093 | Liver Failure |
| D048550 | Hepatic Insufficiency |
Not provided
Not provided
Not provided
Not provided
Not provided
| Hospitalizations | Possible answers: yes or no. If yes, report #of nights and reason. | 5 years |
| Activities of daily living (ADLs) | Six questions about daily activities Scoring: A response of yes to any of the questions receives a value of 1. the ADL score is measured as the sum of the values of the 6 questions. A score of 0 correlates with "most dependent" and a score of 6 is "most independent." | At 1 year post transplantation |
| Instrumental Activities of Daily Living (IADLs) | Eight questions about daily activities: Scoring: each question can be answered with a score of 0 or 1. The final iADL score is the sum of all values. The range of the score is 0 to 8 with 0 being most dependent and 8 being "most independent.' | At 1 year post transplantation |
| 36 Item Short Form Survey Instrument (SF-36) | Patient will complete a 36 question questionnaire about quality of life at 1 year post transplantation. | At 1 year post transplantation |
The changes in frailty score pre and post transplant will be evaluated.
| 5 years |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |